James McCormack
December 11th 2024 - 20.30h CET
Several new classes of glucose-lowering medications have been brought onto the market over the last decade and GPs are being asked to use them and also to try to attain target HbA1cs. However, what really matters to our patients is not their HbA1c but rather living longer and healthier.
So how well do glucose-lowering treatments prevent morbidity and mortality? What are the side effects, and how do we decide which ones to discuss?
In this webinar, we will bring you useful synopses of the best available evidence for the main glucose-lowering treatments for type 2 diabetes and present you with practical hands-on tools to help you discuss treatment options with your patients and help them make decisions that work best for them.
James McCormack received his undergraduate pharmacy degree at the University of British Columbia in 1982 and received his doctorate in pharmacy (Pharm.D.) in 1986 from the Medical University of South Carolina in Charleston, South Carolina.
He focuses on shared decision-making using evidence based information and rational therapeutic principles and he is also the co-host of a very popular weekly podcast called the Best Science (BS) Medicine podcast.
Published on 8 October 2024.